![Longeveron Alzheimer’s Disease Trial]()
by admin | Jan 21, 2018 | News & Opinions, Science
Allogeneic Human Mesenchymal Stem Cell Infusion Versus Placebo in Patients with Alzheimer’s Disease. Longeveron’s Phase I, prospective, randomized, placebo-controlled, double-blinded study is designed to test the safety and efficacy of Longeveron Mesenchymal Stem...
![Longeveron Alzheimer’s Disease Trial]()
by admin | Jan 21, 2018 | News & Opinions, Science
America is facing one of the worst influenza seasons in recent history. The influenza virus is one of the top ten causes of death in elderly people. Longeveron is conducting a multi-center, randomized, placebo controlled trial using its Longeveron Mesenchymal Stem...
![Longeveron Alzheimer’s Disease Trial]()
by admin | Jan 21, 2018 | News & Opinions
PRESS RELEASE Marketwired Jan. 21, 2018, 08:20 AM FREEHOLD, NJ (Marketwired – January 21, 2018) – Avalon GloboCare Corp. (OTCQB: AVCO), a leading global developer of cell-based technologies, announced today that President and Chief Executive Officer David Jin, M.D.,...
![Longeveron Alzheimer’s Disease Trial]()
by admin | Jan 19, 2018 | News & Opinions
The Mayo Clinic Center for Regenerative Medicine is a co-organizer of the 2018 World Stem Cell Summit. More than 1,000 attendees are expected at the 13th annual event Jan. 22-26 in Miami, Florida. Researchers and clinical experts from Mayo Clinic will participate in...
![Longeveron Alzheimer’s Disease Trial]()
by admin | Jan 18, 2018 | News & Opinions
January 18, 2018 – Oakland, CA Over 650,000 Americans suffer from end-stage kidney disease – a life-threatening condition caused by the loss of kidney function. The best available treatment for these patients is a kidney transplant from a genetically...
by admin | Jan 18, 2018 | News & Opinions
The Regenerative Outcomes Foundation is proud to present the Pioneers of Hope, a series of our founder Doug Oliver’s personal interviews with leading influencers in the Regenerative Medicine movement. These articles are our way of sharing the hope that this...
